In this week's power rankings, Ryan Dixon looks at the most promising youngsters or rookies for all 32 teams so far this ...

Indian equity benchmarks continued their losing run today, dragged by FMCG stocks. However, broader markets (mid- and ...

"Even with a decelerating growth rate on huge numbers, Nvidia's CY2025 PEG ratio stands at about 0.8x on our estimates. This ...

X4 Pharmaceuticals ( (XFOR) ) has shared an announcement. X4 Pharmaceuticals has announced promising results from its Phase 2 trial of ...

If you’re looking for a growth stock with the potential for higher returns, Lightspeed stock is the better choice, albeit ...

Morgan Stanley analyst Judah Frommer has maintained their bullish stance on BCAX stock, giving a Buy rating yesterday. Judah Frommer’s ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Thus, I am upgrading ALT stock to a “Strong Buy” due to the promising progress of its lead drug candidate, sufficient runway, ...

With such remarkable results, Mach Conferences & Events Ltd. is well-positioned to capitalize on growth opportunities in the ...

B2Gold faced significant challenges in 2024, including royalty disputes, mine delays, and equipment breakdowns. Read why BTG ...

Excluding India, rest of the EMs struggle with the consistent earnings growth needed for steady capital flows, said Arindam ...

Imugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analysts ...